Clinical trial reportHead & neckPublished
Phase II Trial of Chemotherapy, Cetuximab, and Erlotinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck
Regional connection
Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source
- Institutions
- Fox Chase Cancer Center, Temple Health
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Head & neck
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Head and Neck Neoplasms; Neoplasm Recurrence, Local; Paclitaxel; Carboplatin; Antineoplastic Combined Chemotherapy Protocols; Treatment Outcome; Aged; Middle Aged; Female; Male; Cetuximab
- PubMed ID
- 40166973
- Added to directory
- Source checked